SJS Investment Consulting’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
SJS Investment Consulting's LFCR Position: Q3 2026 in Review
SJS Investment Consulting increased its Lifecore Biomedical (LFCR) stake by 1.6% in Q3 2026, buying an estimated $9 and bringing the position to 130 shares worth $857. The position accounts for ﹤0.01% of the portfolio, ranked #2575.
SJS Investment Consulting first reported a position in LFCR in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.42K in Q4 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- SJS Investment Consulting held 130 shares of Lifecore Biomedical worth $857 as of Q3 2026.
- SJS Investment Consulting bought 2 Lifecore Biomedical shares in Q3 2026, an estimated $9.
- Lifecore Biomedical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2575 holding.
- SJS Investment Consulting first reported a position in Lifecore Biomedical in Q1 2025 and has held it in 7 quarters since.
- SJS Investment Consulting's Lifecore Biomedical position peaked at $1.42K in Q4 2025.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.